» Authors » Charles Goss

Charles Goss

Explore the profile of Charles Goss including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 256
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tobon Ramos J, Maure T, Carias L, Lew D, Goss C, Samuel A, et al.
PLoS Negl Trop Dis . 2025 Mar; 19(3):e0012851. PMID: 40063867
Background: Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF...
2.
Boomer J, Choi J, Alsup A, McGregor M, Lieu J, Johnson C, et al.
Am J Respir Crit Care Med . 2024 Jun; 210(12):1409-1420. PMID: 38935626
The role of IL-13 on the airway epithelium in severe asthma leading to airway remodeling remains poorly understood. To study IL-13-induced airway remodeling on goblet cells and cilia in the...
3.
Amirthanayagam A, ONeill S, Goss C, Moss E
Int J Gynecol Cancer . 2024 Mar; 34(3):459-467. PMID: 38438178
The impact of surgery on the surgeon's well-being encompasses both physical and psychological aspects. Physically, surgeons are at risk of work-related musculoskeletal symptoms due to the nature of their work,...
4.
Mudd P, Borcherding N, Kim W, Quinn M, Han F, Zhou J, et al.
Res Sq . 2023 Oct; PMID: 37790414
SARS-CoV-2 infection and mRNA vaccination induce robust CD4 T cell responses that are critical for the development of protective immunity. Here, we evaluated spike-specific CD4 T cells in the blood...
5.
Martin C, Woolf K, Bryant L, Goss C, Gogoi M, Lagrata S, et al.
Occup Environ Med . 2023 May; 80(7):399-406. PMID: 37221040
Introduction: There are limited data on the outcomes of COVID-19 risk assessment in healthcare workers (HCWs) or the association of ethnicity, other sociodemographic and occupational factors with risk assessment outcomes....
6.
Nazareth J, Barr I, Sullivan S, Goss C, Pan D, Martin C, et al.
J Infect . 2022 Oct; 85(6):e172-e174. PMID: 36243199
No abstract available.
7.
Martin C, Marshall C, Patel P, Goss C, Jenkins D, Ellwood C, et al.
PLoS Med . 2021 Nov; 18(11):e1003823. PMID: 34739480
Background: Healthcare workers (HCWs) and ethnic minority groups are at increased risk of COVID-19 infection and adverse outcomes. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is now available for...
8.
Cao L, Lee S, Krings J, Rauseo A, Reynolds D, Presti R, et al.
Ann Allergy Asthma Immunol . 2021 Feb; 126(5):535-541.e2. PMID: 33639262
Background: Patients with asthma are comparatively susceptible to respiratory viral infections and more likely to develop severe symptoms than people without asthma. During the coronavirus disease 2019 (COVID-19) pandemic, it...
9.
Scozzi D, Cano M, Ma L, Zhou D, Zhu J, OHalloran J, et al.
JCI Insight . 2021 Jan; 6(4). PMID: 33444289
BackgroundMitochondrial DNA (MT-DNA) are intrinsically inflammatory nucleic acids released by damaged solid organs. Whether circulating cell-free MT-DNA quantitation could be used to predict the risk of poor COVID-19 outcomes remains...
10.
Martin C, Jenkins D, Patel P, Goss C, Price A, Barton L, et al.
J Public Health (Oxf) . 2020 Dec; 44(2):255-258. PMID: 33367759
Background: Leicester was the first city in the UK to have 'local lockdown' measures imposed in response to high community rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission....